SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001144204-15-009401
Filing Date
2015-02-17
Accepted
2015-02-17 08:19:27
Documents
1
Group Members
GARY J. MORGENTHALERGARY R. LITTLEJOHN D. LUTSIMORGENTHALER MANAGEMENT PARTNERS VII, L.L.C.PETER G. TAFTROBERT C. BELLAS, JR.ROBERT D. PAVEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A v401569_sc13ga.htm SC 13G/A 131347
  Complete submission text file 0001144204-15-009401.txt   133095
Mailing Address 50 PUBLIC SQUARE SUITE 2700 CLEVELAND OH 44113
Business Address 50 PUBLIC SQUARE SUITE 2700 CLEVELAND OH 44113 216-416-7500
MORGENTHALER PARTNERS VII LP (Filed by) CIK: 0001162183 (see all company filings)

IRS No.: 341949423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87757 | Film No.: 15618023
SIC: 2834 Pharmaceutical Preparations